COVID-19 Mortality Risk in Down Syndrome: Results From a Cohort Study Of 8 Million Adults

Study of 8.26 million adults in England of whom 4053 had Down syndrome, estimated 4-fold increased risk for COVID-19related hospitalisation and a 10-fold increased risk for COVID-19related death, in persons with Down syndrome, a group that is currently not strategically protected

Annals of Internal Medicine